Mantra Bio: Mantra Bio Announces $25 Million Series A Financing to Develop Next Generation Targeted Therapeutics Based on Platform for Engineering Targeted Exosome Vehicles
Mantra Bio announced it has raised $25 million in a Series A financing to advance development of next generation, precision therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles.
Read full article »
Mantra Bio is a California-based biotech firm that develops solutions such as drug delivery and target disease discovery for the healthcare industry.
Read more